New strategy may cut unnecessary pacemakers after heart valve procedure

NCT ID NCT07414485

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new way to predict dangerous heart rhythm problems after a common heart valve procedure called TAVR. Researchers combined ECG results with CT scan measurements and implant depth to see if they could safely identify low-risk patients. The study looked back at 209 patients who had TAVR and were sent home without a pacemaker, tracking who later needed one within three months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this approach could help doctors safely avoid implanting unnecessary pacemakers in many patients after TAVR, reducing procedure risks and healthcare costs.
What could go wrong
This is a retrospective, observational study, not a randomized trial, so the findings may not apply to all patients. The strategy needs prospective validation before changing clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Faculté de médecine montpellier

    Montpellier, 34090, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.